Silence Therapeutics (SLN)
NASDAQ: SLN
· Real-Time Price · USD
5.48
-0.15 (-2.66%)
At close: Aug 15, 2025, 3:59 PM
5.49
0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT
Silence Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.17 | 5.73 | -5.88 | -11.12 | -101.27 | -9.22 | -9.1 | -3.76 | -4.43 | -7.37 | -10.41 | -6.1 | -14.08 | -13.87 | -11.52 | -12.16 | -14.3 |
PEG Ratio | 0.00 | -0.04 | -0.08 | -0.02 | 1.15 | -0.15 | 0.39 | -2.54 | 0.14 | -0.08 | 0.23 | -0.12 | 0.63 | n/a | 0.75 | -0.36 | -0.05 |
PS Ratio | 937.87 | 13.36 | 556.20 | 1.16K | 61.26 | 253.25 | 107.32 | 17.20 | 15.90 | 85.18 | 87.73 | 79.96 | 75.64 | 153.30 | 144.94 | 209.37 | 153.15 |
PB Ratio | 1.18 | 2.42 | 5.02 | 6.15 | 6.13 | 31.18 | 15.02 | 12.78 | 10.90 | 18.39 | 8.67 | -61.45 | 108.47 | 61.38 | 27.96 | 23.89 | 53.15 |
P/FCF Ratio | -10.82 | -13.04 | -32.23 | -141.85 | -101.4 | -44.79 | -61.38 | -10.47 | -23.52 | -29.6 | -31.29 | -35.07 | -30 | -189.96 | -87 | 22.10 | -39.77 |
P/OCF Ratio | -10.82 | -13.07 | -23.35 | -143.83 | -101.4 | -44.8 | -61.64 | -10.47 | -23.62 | -30.27 | -31.45 | -35.23 | -30.11 | -237.35 | -92.84 | 21.72 | -39.82 |
OCF/S Ratio | -86.68 | -1.02 | -23.82 | -8.05 | -0.6 | -5.65 | -1.74 | -1.64 | -0.67 | -2.81 | -2.79 | -2.27 | -2.51 | -0.65 | -1.56 | 9.64 | -3.85 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | -0.01 | 0.02 | 0.02 | 0.01 | 0.01 | n/a |
Quick Ratio | 8.81 | 11.14 | 6.96 | 9.83 | 12.82 | 5.61 | 4.86 | 4.21 | 4.71 | 5.15 | 4.37 | 3.76 | 4.89 | 5.69 | 4.52 | 6.19 | n/a |
Current Ratio | 8.81 | 11.14 | 6.96 | 9.83 | 12.82 | 4.56 | 4.86 | 4.21 | 4.71 | 4.41 | 4.37 | 3.76 | 4.89 | 5.69 | 4.52 | 6.19 | n/a |
Asset Turnover | 0.00 | 0.12 | 0.01 | 0.00 | 0.06 | 0.02 | 0.03 | 0.10 | 0.12 | 0.04 | 0.03 | 0.04 | 0.07 | 0.04 | 0.03 | 0.03 | n/a |
Interest Coverage | n/a | 0.27 | -2.62 | -100.13 | -319.69 | -14.33 | -1.59K | -12.83 | -14.13 | n/a | -400.62 | n/a | n/a | n/a | -191.94 | n/a | -17.59 |
Return on Equity | -0.25 | 0.11 | -0.21 | -0.14 | -0.02 | -0.85 | -0.41 | -0.85 | -0.62 | -0.62 | -0.21 | 2.52 | -1.93 | -1.11 | -0.61 | -0.49 | -0.93 |
Return on Assets | -0.15 | 0.07 | -0.16 | -0.08 | -0.01 | -0.15 | -0.08 | -0.11 | -0.11 | -0.13 | -0.06 | -0.14 | -0.09 | -0.1 | -0.11 | -0.12 | n/a |
Return on Invested Capital | -0.17 | -0.01 | -0.14 | -0.1 | -0.01 | -0.17 | -0.12 | -0.14 | -0.13 | -0.12 | -0.11 | -0.2 | -0.11 | -0.12 | -0.14 | -0.14 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.62 | 0.93 | -1.43 | -3.41 | 0.82 | 0.36 | 0.43 | 0.69 | 0.60 | 0.19 | 0.29 | 0.35 | 0.60 | 0.40 | 0.35 | 0.32 | 0.51 |
Net Profit Margin | -200.92 | 0.58 | -23.65 | -26.02 | -0.15 | -6.87 | -2.95 | -1.14 | -0.9 | -2.89 | -2.11 | -3.28 | -1.34 | -2.76 | -3.15 | -4.31 | -2.68 |
Pretax Profit Margin | -200.92 | 0.98 | -26.41 | -29.17 | -0.27 | -7.13 | -3.81 | -1.32 | -1.11 | -3.16 | -2.77 | -3.68 | -1.67 | -3.29 | -3.82 | -4.7 | -3.14 |
Operating Profit Margin | -200.06 | -0.13 | -19.73 | -30.64 | -0.33 | -6.34 | -4.54 | -1.26 | -1.07 | -2.3 | -4.04 | -3.87 | -1.73 | -3.3 | -3.89 | -4.79 | -2.97 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -200.06 | 0.30 | -18.77 | -28.66 | -0.33 | -7.1 | -3.76 | -1.21 | -1.03 | -2.28 | -2.72 | -3.65 | -1.65 | -3.28 | -3.76 | -4.66 | -2.93 |